|
1
|
Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
|
J Gastroenterol Hepatol
|
2003
|
1.23
|
|
2
|
Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells.
|
BMC Cancer
|
2009
|
1.11
|
|
3
|
Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.
|
Cancer Sci
|
2007
|
1.08
|
|
4
|
Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach.
|
J Proteome Res
|
2009
|
1.06
|
|
5
|
Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
|
Clin Cancer Res
|
2009
|
1.04
|
|
6
|
Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
|
Oncol Rep
|
2010
|
0.98
|
|
7
|
The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
|
Ann Surg Oncol
|
2011
|
0.97
|
|
8
|
Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug.
|
Med Oncol
|
2013
|
0.97
|
|
9
|
Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection.
|
Gut
|
2010
|
0.96
|
|
10
|
Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
|
Int J Biochem Cell Biol
|
2012
|
0.96
|
|
11
|
A three-dimensional cell biology model of human hepatocellular carcinoma in vitro.
|
Tumour Biol
|
2010
|
0.95
|
|
12
|
Cell surface glycan alterations in epithelial mesenchymal transition process of Huh7 hepatocellular carcinoma cell.
|
PLoS One
|
2013
|
0.94
|
|
13
|
Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion.
|
Biochem Biophys Res Commun
|
2007
|
0.94
|
|
14
|
Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
|
BMC Cancer
|
2012
|
0.94
|
|
15
|
N-linked glycan changes of serum haptoglobin β chain in liver disease patients.
|
Mol Biosyst
|
2011
|
0.93
|
|
16
|
Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78.
|
PLoS One
|
2013
|
0.93
|
|
17
|
Comparative glycoproteomics based on lectins affinity capture of N-linked glycoproteins from human Chang liver cells and MHCC97-H cells.
|
Proteomics
|
2007
|
0.89
|
|
18
|
Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.
|
Cancer Lett
|
2011
|
0.89
|
|
19
|
Proteome analysis of aflatoxin B1-induced hepatocarcinogenesis in tree shrew (Tupaia belangeri chinensis) and functional identification of candidate protein peroxiredoxin II.
|
Proteomics
|
2008
|
0.89
|
|
20
|
Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
|
Acta Biochim Biophys Sin (Shanghai)
|
2012
|
0.88
|
|
21
|
Glycan-related gene expression signatures in human metastatic hepatocellular carcinoma cells.
|
Exp Ther Med
|
2011
|
0.87
|
|
22
|
Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification.
|
J Cancer Res Clin Oncol
|
2007
|
0.87
|
|
23
|
Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS.
|
J Cancer Res Clin Oncol
|
2010
|
0.86
|
|
24
|
[Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
|
Zhonghua Yi Xue Za Zhi
|
2002
|
0.86
|
|
25
|
High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques.
|
Med Oncol
|
2013
|
0.85
|
|
26
|
Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.
|
Mol Biosyst
|
2011
|
0.85
|
|
27
|
Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to α fetoprotein.
|
Oncol Rep
|
2010
|
0.83
|
|
28
|
Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
|
Chin Med J (Engl)
|
2003
|
0.83
|
|
29
|
Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
|
Acta Biochim Biophys Sin (Shanghai)
|
2013
|
0.82
|
|
30
|
Increased claudin-3, -4 and -18 levels in bronchoalveolar lavage fluid reflect severity of acute lung injury.
|
Respirology
|
2013
|
0.81
|
|
31
|
Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
|
Glycoconj J
|
2015
|
0.81
|
|
32
|
Nanozeolite-driven approach for enrichment of secretory proteins in human hepatocellular carcinoma cells.
|
Proteomics
|
2009
|
0.81
|
|
33
|
Dynamic alteration of protein expression profiles during neoplastic transformation of rat hepatic oval-like cells.
|
Cancer Sci
|
2010
|
0.80
|
|
34
|
Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI-D20) with high metastasis potential.
|
Proteomics
|
2006
|
0.80
|
|
35
|
Systematic analyses of the transcriptome, translatome, and proteome provide a global view and potential strategy for the C-HPP.
|
J Proteome Res
|
2013
|
0.79
|
|
36
|
Quantitative proteomic analysis of a paired human liver healthy versus carcinoma cell lines with the same genetic background to identify potential hepatocellular carcinoma markers.
|
Proteomics Clin Appl
|
2009
|
0.79
|
|
37
|
Proteome alteration of early-stage differentiation of mouse embryonic stem cells into hepatocyte-like cells.
|
Electrophoresis
|
2009
|
0.79
|
|
38
|
Chromosome-8-coded proteome of Chinese Chromosome Proteome Data set (CCPD) 2.0 with partial immunohistochemical verifications.
|
J Proteome Res
|
2013
|
0.79
|
|
39
|
Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.
|
Acta Biochim Biophys Sin (Shanghai)
|
2011
|
0.79
|
|
40
|
The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector.
|
Mol Biol Rep
|
2013
|
0.78
|
|
41
|
Decreased expression of the human carbonyl reductase 2 gene HCR2 in hepatocellular carcinoma.
|
Cell Mol Biol Lett
|
2006
|
0.78
|
|
42
|
Identification and analysis of alpha1,6-fucosylated proteins in human normal liver tissues by a target glycoproteomic approach.
|
Electrophoresis
|
2007
|
0.78
|
|
43
|
Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway.
|
Cell Physiol Biochem
|
2015
|
0.78
|
|
44
|
Proteomic study explores AGR2 as pro-metastatic protein in HCC.
|
Mol Biosyst
|
2012
|
0.78
|
|
45
|
Enhancing TOF/TOF-based de novo sequencing capability for high throughput protein identification with amino acid-coded mass tagging.
|
J Proteome Res
|
2005
|
0.78
|
|
46
|
Preliminary study of proteomic shift from normal to premalignant laryngeal lesions and to laryngeal squamous cell carcinoma.
|
Acta Otolaryngol
|
2009
|
0.77
|
|
47
|
Systematic analysis of missing proteins provides clues to help define all of the protein-coding genes on human chromosome 1.
|
J Proteome Res
|
2013
|
0.77
|
|
48
|
DSA affinity glycoproteome of human liver tissue.
|
Arch Biochem Biophys
|
2009
|
0.77
|
|
49
|
Investigation on glycosylation patterns of proteins from human liver cancer cell lines based on the multiplexed proteomics technology.
|
Arch Biochem Biophys
|
2006
|
0.77
|
|
50
|
Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.
|
Chin Med J (Engl)
|
2003
|
0.77
|
|
51
|
[Alteration of the glycan profile of serum glycoproteins during the seroconversion process in hepatitis B virus-infected patients treated with antiviral therapy and its clinical significance].
|
Zhonghua Gan Zang Bing Za Zhi
|
2014
|
0.77
|
|
52
|
iTRAQ plus 18O: a new technique for target glycoprotein analysis.
|
Talanta
|
2012
|
0.76
|
|
53
|
[Gene expression profile of human hepatocellular carcinoma cell lines with different metastatic potentials].
|
Zhonghua Zhong Liu Za Zhi
|
2002
|
0.76
|
|
54
|
Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy.
|
Chin Med J (Engl)
|
2002
|
0.76
|
|
55
|
Role of PKCbeta in hepatocellular carcinoma cells migration and invasion in vitro: a potential therapeutic target.
|
Clin Exp Metastasis
|
2008
|
0.76
|
|
56
|
Comprehensive profiling of metastasis-related proteins in paired hepatocellular carcinoma cells with different metastasis potentials.
|
Proteomics Clin Appl
|
2009
|
0.75
|
|
57
|
Effects of galectin-3 inhibition on endometrial cell cycle and adhesion.
|
Front Med China
|
2007
|
0.75
|
|
58
|
Studies on peptide acetylation for stable-isotope labeling after 1-D PAGE separation in quantitative proteomics.
|
Proteomics
|
2004
|
0.75
|
|
59
|
[Immunoprotective effect of IL-2 and B7-1 gene co-transfected liver cancer vaccines on hepatocarcinogenesis in mice].
|
Zhonghua Gan Zang Bing Za Zhi
|
2002
|
0.75
|
|
60
|
Detection and quantification of lysine acetyl-alteration using antibody microarray.
|
Bioanalysis
|
2013
|
0.75
|
|
61
|
Recombinant human heparin-binding neurite-promoting factor expressed with yeast stimulates neurites outgrowth.
|
Chin Med J (Engl)
|
2002
|
0.75
|
|
62
|
[Serum glycoprotein profiling by lectin affinity microarray to distinguish the various stages of primary liver carcinogenesis].
|
Zhonghua Gan Zang Bing Za Zhi
|
2014
|
0.75
|
|
63
|
[Evaluation of isotopic labeling of lysine residues of peptides for quantitative proteomics].
|
Sheng Wu Gong Cheng Xue Bao
|
2012
|
0.75
|